Plain-English translation of NCT04645199 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Myeloma research guide →This is a large registry study that gathers information about patients with various blood disorders—including leukemia, lymphoma, multiple myeloma, hemophilia, and others—to better understand these diseases. Researchers will review medical records from patients diagnosed since 2020 to learn about how blood diseases develop, what treatments work best, how patients fare over time, and the costs of care.
China currently lacks large, comprehensive studies that follow blood disease patients over time. By collecting data from thousands of patients across multiple hospitals, this research will help doctors understand which patients are at highest risk, what treatments are most effective, and how to improve care and reduce costs.
You likely qualify if…
You likely don't qualify if…
You would not need to take any medication or undergo new procedures. Instead, the research team would collect information from your existing medical records—including your diagnosis, treatments you've received, and how you're doing. The study will also contact you periodically to gather updated information about your health and progress over time.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
China